BiopharmaTrend.com

Massive Bio

Massive Bio

Private company
MASSIVE BIO
New York

Massive Bio is a marketplace that connects cancer patients and their treating oncologists to clinical trials and advanced care plans while enabling enterprises to get access to patients at community practices to enhance oncology research. Massive Bio provides virtual tumor board, clinical trial services (patient identification, pre-screening, site selection) and real-world evidence services. Massive Bio’s enterprise customers are Contract Research Organizations (CROs), pharmaceutical companies, diagnostics labs and providers. Massive Bio combines patient acquisition, Artificial Intelligence (AI) based scalable pre-screening, operationalization support and real world data to connect patients to oncology trials.


Founded
2015
Status
Private company
Geography
United States of America based
Funding
$4 M
Clinical Trials
1

Products

SYNERGY-AI

Our Artificial Intelligence (AI) based technology precisely identifies and matches patients clinical trials in community practices. Our proprietary technology is …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page